Published in Support Care Cancer on November 14, 2002
Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain. Br J Cancer (2007) 0.94
The Supportive Care Task Force at the University of L'Aquila: 2-years experience. Support Care Cancer (2005) 0.92
Pattern and characteristics of advanced cancer patients admitted to hospices in Italy. Support Care Cancer (2012) 0.87
The Palliative-Supportive Care Unit in a Comprehensive Cancer Center as Crossroad for Patients' Oncological Pathway. PLoS One (2016) 0.85
Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit. Support Care Cancer (2013) 0.80
Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit. Support Care Cancer (2013) 0.77
Characteristics of patients with an unplanned admission to an acute palliative care unit. Intern Emerg Med (2017) 0.77
Clarifications on oxycodone-naloxone combination in cancer pain management. Support Care Cancer (2012) 0.76
Palliative patients under anaesthesiological care: a single-centre retrospective study on incidence, demographics and outcome. BMC Anesthesiol (2015) 0.75
[Anesthesiology and palliative medicine. Structured results of a prospective questionnaire-based survey in German hospitals]. Schmerz (2011) 0.75
Characteristics of advanced cancer patients who were readmitted to an acute palliative/supportive care unit. Support Care Cancer (2017) 0.75
The effects of alcoholism and smoking on advanced cancer patients admitted to an acute supportive/palliative care unit. Support Care Cancer (2017) 0.75
High doses of oxycodone-naloxone combination may provide poor analgesia. Support Care Cancer (2011) 1.65
CT-guided neurolytic splanchnic nerve block by an anterior approach. J Pain Symptom Manage (2002) 1.39
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain (2008) 1.04
Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage (2009) 1.00
Aggressive pharmacological treatment for reversing malignant bowel obstruction. J Pain Symptom Manage (2004) 0.99
Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer (2004) 0.98
Peritoneal catheter for continuous drainage of ascites in advanced cancer patients. Support Care Cancer (2008) 0.97
Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage (2004) 0.97
Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage (2005) 0.96
High-dose furosemide and small-volume hypertonic saline solution infusion for the treatment of leg edema in advanced cancer patients. J Pain Symptom Manage (2008) 0.96
The use of high doses of oxycodone in an acute palliative care unit. Am J Hosp Palliat Care (2010) 0.96
Opioid escalation in patients with cancer pain: the effect of age. J Pain Symptom Manage (2006) 0.95
Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain (2007) 0.93
Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage (2008) 0.91
Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manage (2003) 0.91
Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin (2012) 0.91
Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation. Oncology (2002) 0.90
Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. J Pain Symptom Manage (2004) 0.90
Patients' and relatives' perceptions about intravenous and subcutaneous hydration. J Pain Symptom Manage (2005) 0.89
Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine. J Pain Symptom Manage (2006) 0.87
Opioid-induced or pain relief-reduced symptoms in advanced cancer patients? Eur J Pain (2006) 0.87
Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer (2002) 0.87
Low doses of transdermal fentanyl in opioid-naive patients with cancer pain. Curr Med Res Opin (2010) 0.85
Effects of red blood cell transfusion on anemia-related symptoms in patients with cancer. J Palliat Med (2009) 0.85
Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol (2005) 0.84
An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Support Care Cancer (2010) 0.84
The use of opioids for breakthrough pain in acute palliative care unit by using doses proportional to opioid basal regimen. Clin J Pain (2010) 0.84
Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose. J Pain Symptom Manage (2011) 0.84
Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study. Clin Ther (2009) 0.83
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. J Pain (2009) 0.82
Low morphine doses in opioid-naive cancer patients with pain. J Pain Symptom Manage (2006) 0.82
Burst ketamine to reverse opioid tolerance in cancer pain. J Pain Symptom Manage (2003) 0.81
Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain. Support Care Cancer (2005) 0.81
Outcome of opioid switching 4 weeks after discharge from a palliative care unit. Curr Med Res Opin (2011) 0.80
Local anesthetics for breakthrough pain in patients receiving intrathecal treatment for cancer pain management. Anesth Analg (2005) 0.80
Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients. Support Care Cancer (2006) 0.80
When the progression of disease lowers opioid requirement in cancer patients. Clin J Pain (2010) 0.79
Does pain intensity predict a poor opioid response in cancer patients? Eur J Cancer (2011) 0.79
Withdrawal acute psychosis after corticosteroid discontinuation. J Pain Symptom Manage (2007) 0.79
The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients. Clin J Pain (2013) 0.78
The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study. Support Care Cancer (2010) 0.78
Tracheal stent to repair tracheal laceration after a double-lumen intubation. Ann Thorac Surg (2012) 0.78
Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori (2002) 0.77
Itraconazole-fentanyl interaction in a cancer patient. J Pain Symptom Manage (2002) 0.77
Refractory death rattle: deep aspiration facilitates the effects of antisecretory agents. J Pain Symptom Manage (2010) 0.77
Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases. Clin J Pain (2009) 0.76
Prevalence of opioid-related dysuria in patients with advanced cancer having pain. Am J Hosp Palliat Care (2010) 0.76
The use of opioids in the last week of life in an acute palliative care unit. Am J Hosp Palliat Care (2010) 0.75
Effectiveness and tolerability of amidotrizoate for the treatment of constipation resistant to laxatives in advanced cancer patients. J Pain Symptom Manage (2010) 0.75
Switching from oxycodone to methadone in advanced cancer patients. Support Care Cancer (2011) 0.75
Intravenous morphine for breakthrough (episodic-) pain in an acute palliative care unit: a confirmatory study. J Pain Symptom Manage (2008) 0.75
Frequency and Indications of Parenteral Nutrition in an Acute Palliative Care Unit. Nutr Cancer (2015) 0.75
Opioid plasma concentrations during a switch from transdermal fentanyl to methadone. J Palliat Med (2007) 0.75
Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain. Support Care Cancer (2014) 0.75
Prolonged uncontrolled pain, psychological distress, and opioid escalation. J Pain Symptom Manage (2004) 0.75
A randomized-controlled study of intrathecal versus epidural thoracic analgesia in patients undergoing abdominal cancer surgery. J Clin Monit Comput (2008) 0.75
Switching from methadone to tapentadol for cancer pain. J Pain Symptom Manage (2012) 0.75
Phase I-II parallel study of docetaxel on a bimonthly schedule in refractory metastatic breast carcinoma. Breast Cancer Res Treat (2003) 0.75
Block of interdigital nerves for cancer pain. J Pain Symptom Manage (2002) 0.75
Naloxone in treating central adverse effects during opioid titration for cancer pain. J Pain Symptom Manage (2003) 0.75
Dialogues on complex analgesic strategies for difficult pain syndromes. Support Care Cancer (2004) 0.75
Noninvasive ventilation for the treatment of dyspnea as a bridge from intensive to end-of-life care. J Pain Symptom Manage (2009) 0.75
Bedside anesthesia for painful procedures in onco-hematology. J Palliat Med (2008) 0.75